Sterling Investment Advisors (Pennsylvania)’s Medicus Pharma MDCX Stock Holding History

Sterling Investment Advisors (Pennsylvania)’s Portfolio MDCX Stock Details MDCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$44.6K	Buy	+100,000	New	+$35.4K	0.01%	224

Other funds holding MDCX

ICP

Interchange Capital Partners Pittsburgh, Pennsylvania $532M AUM 26.57% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

WSFS

Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return

MCM

Marathon Capital Management Hunt Valley, Maryland $494M AUM 42.6% 1-Year Est. Return

Sterling Investment Advisors (Pennsylvania)'s MDCX Position: Q2 2026 in Review

Sterling Investment Advisors (Pennsylvania) opened a new position in Medicus Pharma (MDCX) in Q2 2026: 100,000 shares worth $44.6K. The stake represents 0.01% of the portfolio and ranks #224 among its holdings.

5 funds tracked by Wall St. Rank hold MDCX as of Q2 2026.

Sterling Investment Advisors (Pennsylvania) held 100,000 shares of Medicus Pharma worth $44.6K as of Q2 2026.
Medicus Pharma was a new Sterling Investment Advisors (Pennsylvania) position in Q2 2026.
Medicus Pharma made up 0.01% of Sterling Investment Advisors (Pennsylvania)'s portfolio in Q2 2026, its #224 holding.
5 funds tracked by Wall St. Rank held Medicus Pharma as of Q2 2026.

Based on Sterling Investment Advisors (Pennsylvania)'s 13F filing for Q2 2026, filed 28 Jul 2026.